Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Van Damme

Showing results (1-10 of 251) with videos related to

Pageof 26
Sort By:
Vaccine|March 21, 2001
Hepatitis B: vaccination programmes in Europe--an updateP Van Damme
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 21, 2010
The role of AMPA receptors and VEGF in ALSP Van Damme
Occupational Health; a Journal for Occupational Health Nurses|August 1, 1996
Hepatitis A, B and C occupational hazardsP Van Damme
International Surgery|July 1, 1985
A preperitoneal approach in the prosthetic repair of inguinal herniaJ P Van Damme
Vaccine|January 1, 1995
Proceedings of the International Congress. Action towards control of hepatitis B as a community health risk. Cannes 22-24 November 1993. IntroductionP Van Damme, M Kane
Acta Gastro-Enterologica Belgica|July 11, 1998
Epidemiology of hepatitis B and C in EuropeP Van Damme, A Vellinga
Vaccine|July 17, 2007
Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newbornsE Leuridan, P Van Damme
The New England Journal of Medicine|July 5, 1990
Hepatitis C in institutionalized childrenR Vranckx, P Van Damme
Pharmacoeconomics|December 9, 1995
Economic evaluation of vaccinationP Van Damme, P Beutels
Vaccine|November 19, 1997
Prevention and control of hepatitis B in central and eastern Europe and the newly independent states, Siofok, Hungary, 6-9 October 1996D FitzSimons, P Van Damme
Pageof 26

Showing results (1-10 of 251) with videos related to

Sort By:
Pageof 26
Vaccine|March 21, 2001
Hepatitis B: vaccination programmes in Europe--an updateP Van Damme
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 21, 2010
The role of AMPA receptors and VEGF in ALSP Van Damme
Occupational Health; a Journal for Occupational Health Nurses|August 1, 1996
Hepatitis A, B and C occupational hazardsP Van Damme
International Surgery|July 1, 1985
A preperitoneal approach in the prosthetic repair of inguinal herniaJ P Van Damme
Vaccine|January 1, 1995
Proceedings of the International Congress. Action towards control of hepatitis B as a community health risk. Cannes 22-24 November 1993. IntroductionP Van Damme, M Kane
Acta Gastro-Enterologica Belgica|July 11, 1998
Epidemiology of hepatitis B and C in EuropeP Van Damme, A Vellinga
Vaccine|July 17, 2007
Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newbornsE Leuridan, P Van Damme
The New England Journal of Medicine|July 5, 1990
Hepatitis C in institutionalized childrenR Vranckx, P Van Damme
Pharmacoeconomics|December 9, 1995
Economic evaluation of vaccinationP Van Damme, P Beutels
Vaccine|November 19, 1997
Prevention and control of hepatitis B in central and eastern Europe and the newly independent states, Siofok, Hungary, 6-9 October 1996D FitzSimons, P Van Damme
Pageof 26